Physician profile
Craig W Boyd
NPI 1821171927
$4,548.38
in general payments reported to CMS, 2019-2025
43 companies · $486 in 2025
The $486 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $690 · 2020: $256 · 2021: $741 · 2022: $1,360 · 2023: $632 · 2024: $384 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,501.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $720.90 | 2019-2023 | Ubrelvy, Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $394.80 | 2022-2025 | Veozah, Myrbetriq |
| Evofem Biosciences, INC. | $302.85 | 2020-2025 | Phexxi, Solosec, Phexx |
| Intuitive Surgical, INC. | $271.26 | 2021-2022 | |
| Hologic Sales and Service, LLC | $208.60 | 2019-2025 | Third Wave, Thinprep 2000 Processor, Aptima |
| Pfizer INC. | $195.32 | 2019-2025 | |
| Therapeuticsmd, INC. | $170.68 | 2019-2022 | |
| Lupin INC. | $165.80 | 2019-2021 | |
| Exeltis, USA INC. | $164.11 | 2019-2025 | Slynd |
| Agile Therapeutics, INC. | $162.78 | 2021-2024 | Twirla |
| Meditrina | $160.90 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $146.64 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $143.09 | 2021-2025 | |
| Organon LLC | $134.88 | 2022-2025 | Nexplanon, Jada System |
| Avion Pharmaceuticals | $129.68 | 2019-2023 | Balcoltra |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.